To be clear on 21 Sep 2023 we had results for Bis + Dox (86% improvement when used in combo) and now Bis + Dec (92% in combo) both screened in 143 cell lines.So we have shown excellent preclinical efficacy in the most broadly used cancer treatments in solid and blood tumours.
@reon1- if I understand this correctly, this research further supports the investigator initiated AML trials in Australia and not a separate set of AML trials.
Otsuka, the ball is in your court.
- Forums
- ASX - By Stock
- Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
To be clear on 21 Sep 2023 we had results for Bis + Dox (86%...
-
- There are more pages in this discussion • 95 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.63 |
Change
-0.060(3.55%) |
Mkt cap ! $269.2M |
Open | High | Low | Value | Volume |
$1.66 | $1.66 | $1.57 | $248.2K | 152.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1973 | $1.63 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.64 | 1880 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1973 | 1.630 |
1 | 3762 | 1.620 |
1 | 5115 | 1.615 |
1 | 2000 | 1.610 |
1 | 625 | 1.600 |
Price($) | Vol. | No. |
---|---|---|
1.640 | 1880 | 2 |
1.645 | 688 | 1 |
1.650 | 1400 | 1 |
1.660 | 20000 | 1 |
1.690 | 6000 | 1 |
Last trade - 13.03pm 04/10/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |